Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KITE

Kite Pharma

$109.15

-0.74 (-0.67%)

12:15
07/24/17
07/24
12:15
07/24/17
12:15
Options
Kite Pharma put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Thursday
KITE

Kite Pharma

$105.43

2.11 (2.04%)

08:34
07/20/17
07/20
08:34
07/20/17
08:34
Hot Stocks
Kite Pharma highlights data from Anti-CD19 CAR T-Cell therapy study »

Kite Pharma highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Over a week ago
NVS

Novartis

$82.55

-0.66 (-0.79%)

, KITE

Kite Pharma

$103.36

-1.29 (-1.23%)

18:12
07/13/17
07/13
18:12
07/13/17
18:12
Periodicals
Three drugmakers may capitalize on Novartis' cancer therapy, Barron's reports »

Novartis' (NVS)…

NVS

Novartis

$82.55

-0.66 (-0.79%)

KITE

Kite Pharma

$103.36

-1.29 (-1.23%)

JUNO

Juno Therapeutics

$28.06

0.03 (0.11%)

BLUE

bluebird bio

$96.00

0.3 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 29

    Nov

KITE

Kite Pharma

$104.65

0.95 (0.92%)

15:08
07/13/17
07/13
15:08
07/13/17
15:08
Downgrade
Kite Pharma rating change  »

Kite Pharma downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

KITE

Kite Pharma

$104.65

0.95 (0.92%)

14:59
07/13/17
07/13
14:59
07/13/17
14:59
Downgrade
Kite Pharma rating change at Maxim »

Kite Pharma downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

KITE

Kite Pharma

$104.65

0.95 (0.92%)

, JUNO

Juno Therapeutics

$28.03

0.14 (0.50%)

05:55
07/13/17
07/13
05:55
07/13/17
05:55
Recommendations
Kite Pharma, Juno Therapeutics, Novartis analyst commentary at Citi »

Novartis vote bodes well…

KITE

Kite Pharma

$104.65

0.95 (0.92%)

JUNO

Juno Therapeutics

$28.03

0.14 (0.50%)

NVS

Novartis

$83.21

1.22 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 29

    Nov

KITE

Kite Pharma

$105.63

2.07 (2.00%)

, NVS

Novartis

$82.14

-0.18 (-0.22%)

11:27
07/10/17
07/10
11:27
07/10/17
11:27
Recommendations
Kite Pharma, Novartis analyst commentary at Jefferies »

Jefferies ups Kite target…

KITE

Kite Pharma

$105.63

2.07 (2.00%)

NVS

Novartis

$82.14

-0.18 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

  • 18

    Jul

  • 29

    Nov

KITE

Kite Pharma

$105.63

2.07 (2.00%)

10:45
07/10/17
07/10
10:45
07/10/17
10:45
Recommendations
Kite Pharma analyst commentary at Jefferies »

Kite Pharma price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

KITE

Kite Pharma

$100.43

-0.23 (-0.23%)

11:25
06/27/17
06/27
11:25
06/27/17
11:25
Options
Kite Pharma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

KITE

Kite Pharma

$100.43

-0.23 (-0.23%)

, NVS

Novartis

$85.75

-0.59 (-0.68%)

07:13
06/27/17
06/27
07:13
06/27/17
07:13
Recommendations
Kite Pharma, Novartis analyst commentary at Canaccord »

Kite Pharma has…

KITE

Kite Pharma

$100.43

-0.23 (-0.23%)

NVS

Novartis

$85.75

-0.59 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 12

    Jul

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.